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Abstract.	
	
Chronic	 heart	 failure	 is	 often	 accompanied	 by	 comorbidities	 including	
obesity	being	the	major	one.	It	significantly	aggravates	the	course	of	the	disease	
and	clinical	outcome.	Changes	 in	the	plasma	concentration	of	 lipids	 in	chronic	
heart	 failure	 were	 demonstrated	 by	 many	 studies.	 Recently	 a	 considerable	
number	of	works	has	appeared	 in	which	a	negative	 influence	of	both	high	and	
low	 levels	of	 lipids	on	 the	 course,	 consequences	and	 survival	 in	patients	with	
chronic	heart	failure	was	observed.	
	 The	objective	of	the	research	was	to	study	gender-based	and	age-related	
peculiarities	of	lipid	metabolism	in	chronic	heart	failure	secondary	to	overweight	
and	obesity.	
	 Material	and	methods.	There	were	examined	212	patients	with	chronic	
heart	 failure	 functional	 class	 I-III	 having	 normal	 body	 weight,	 I-III	 degree	
abdominal	 obesity	 or	 being	 overweight.	 Patients	 underwent	 complete	 blood	
count	and	biochemical	blood	analysis;	instrumental	examination	was	performed	
according	 to	 the	existing	guidelines	 for	 the	diagnosis	and	 treatment	of	chronic	
heart	failure.	Statistical	processing	of	the	obtained	material	was	performed	using	
an	advanced	analytics	software	package	Statistica	6.0.	
	 Results	 and	 discussion.	 Both	 atherogenic	 and	 antiatherogenic	
components	of	lipid	metabolism	predominated	in	females.	Age-related	changes	
were	 presented	 by	 higher	 levels	 of	 atherogenic	 indices	 and	 prevalence	 of	
dyslipidemia	in	young	patients	reducing	with	age	in	parallel	with	the	deepening	
of	chronic	heart	failure.	
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Problem	statement	and	analysis	of	the	recent	research	
Chronic	heart	failure	 (CHF)	 is	often	accompanied	by	comorbidities	 including	obesity	being	
the	 major	 one.	 It	 significantly	 aggravates	 the	 course	 of	 the	 disease	 and	 clinical	 outcome	 [1].	
Changes	 in	 the	plasma	concentration	of	 lipids	 in	CHF	were	demonstrated	by	many	studies	 [2-6].	
The	 epidemiological	 studies	 demonstrated	 that	 dyslipidemia	 can	 directly	 influence	 the	
development	and	progression	of	CHF	 [11].	Low	 levels	of	atherogenic	 lipids	and	elevated	 levels	of	
anti-atherogenic	 ones	 are	 of	 undoubted	 importance	 in	 the	 development	 and	 progression	 of	
atherosclerosis	and	ischemic	heart	disease	(IHD)	which	is	especially	important	considering	the	fact	
that	up	to	70%	of	cases	of	CHF	are	of	ischemic	genesis	[9].	Therapeutic	tactics	in	dyslipidemia	aimed	
at	reducing	the	concentration	of	atherogenic	and	increasing	the	anti-atherogenic	fractions	of	lipids	
is	 the	 basis	 for	 primary	 and	 secondary	 prevention	 [3].	 Several	 preclinical	 and	 clinical	 studies	
allowed	 the	 use	 of	 statins	 in	 patients	 with	 CHF	 [4,	 7,	 10]	 concentrating	 their	 arguments	 on	
pleiotropy	effect,	ability	 to	 improve	endothelial	dysfunction	of	blood	vessels	as	well	as	 to	reduce	
inflammatory	processes	–	the	main	links	in	the	pathogenesis	of	CHF	independently	of	cholesterol	
lowering	[6,	8].	However,	recently	a	considerable	number	of	works	has	appeared	in	which	a	negative	
influence	of	both	high	and	low	levels	of	lipids	on	the	course,	consequences	and	survival	in	patients	
with	chronic	heart	failure	was	observed	[2,	5].		
Considering	the	continuous	 incidence	of	CHF	with	concomitant	overweight	and	obesity,	a	
small	number	of	research	works	related	to	study	of	 lipid	metabolism,	polarity	of	views	regarding	
the	 prognostic	 significance	 of	 lipid	 levels	 in	 these	 patients,	 the	 chosen	 direction	 of	 research	 is	
timely	and	relevant.	
The	 objective	 of	 the	 research	was	 to	 study	 gender-based	 and	 age-related	peculiarities	 of	
lipid	metabolism	in	chronic	heart	failure	secondary	to	overweight	and	obesity.	
	
Material	and	methods	
There	were	examined	212	patients	with	CHF	functional	class	 (FC)	I-III	having	normal	body	
weight,	 I-III	degree	 abdominal	obesity	or	being	overweight.	 Patients	were	 treated	 in	 the	Central	
Clinical	Hospital	No	4,	Zaporizhzhya.	The	diagnosis	of	CHF	was	made	according	to	the	Guidelines	
of	 the	Ukrainian	Association	of	Cardiology	and	 the	Ukrainian	Association	of	Specialists	 in	Heart	
Failure	on	 the	diagnosis	and	 treatment	of	CHF	 (2012)	 [1].	FC	of	CHF	was	determined	according	 to	
the	New	York	Heart	Association	 (NYHA)	Functional	Classification.	The	presence	of	normal	body	
weight,	overweight,	obesity	and	its	degree	was	determined	by	calculation	of	the	body	mass	index	
(BMI).	CHF	was	induced	by	arterial	hypertension	(AH),	chronic	forms	of	ischemic	heart	disease	(IHD)	
(stable	angina,	post-infarction	(PICS)	and	diffuse	cardiosclerosis),	and	their	combinations.	
The	 study	 was	 conducted	 according	 to	 the	 standards	 of	 Good	 Clinical	 Practice	 and	 the	
principles	 of	 the	 Helsinki	 Declaration.	 The	 Ethical	 Committee	 of	 Zaporizhzhya	 State	 Medical	
University	approved	the	protocol;	only	patients	who	gave	written	informed	consent	were	included	
in	this	study.	
Patients	 underwent	 complete	 blood	 count	 and	 biochemical	 blood	 analysis,	 instrumental	
examination	was	performed	according	to	the	existing	guidelines	 for	the	diagnosis	and	treatment	
of	 CHF.	 The	 levels	 of	 total	 cholesterol	 (TC),	 high-density	 lipoprotein	 cholesterol	 (HDL-С),	
triglycerides	 (TG)	were	determined.	The	 level	of	 low-density	 lipoprotein	 cholesterol	 (LDL-C)	was	
calculated	by	the	Friedewald	formula:	LDL-C=TC–HDL-C–(0.45	x	TG).	The	level	of	very-low-density	
lipoproteins	cholesterol	 (VLDL-C)	was	determined	according	 to	 the	 formula:	VLDL-C=TG/2.2.	The	
atherogenic	coefficient	(AC)	was	calculated	by	the	formula	proposed	by	Klimov	AM	–	AC	=	(TC–HDL-
C)/HDL-C.	 Integral	 indicators	 of	 atherogenic	 and	 anti-atherogenic	 fractions	 of	 lipids	 were	
determined	as	the	TG/HDL-C	and	LDL-C/HDL-C	ratios.		
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Statistical	processing	of	 the	obtained	material	was	performed	using	an	advance	analytics	
software	package	Statistica	(version	6.0,	Stat	Soft	Inc,	USA,	license	number	AXXR712D833214FAN5).	
The	hypothesis	of	normality	of	distribution	of	parameters	was	checked	by	the	Shapiro-Wilk	test.	
According	 to	 the	 sample	 size	 and	 distribution	 of	 values	 parametric	 (Student’s	 t-test)	 and	
nonparametric	 statistical	 methods	 (Mann-Whitney	 U	 test)	 were	 used.	 The	 comparison	 of	
categorical	 variables	 was	 performed	 using	 bilateral	 Fisher’s	 exact	 test	 or	 chi-square	 test.	 The	
relations	 between	 the	 indicators	 were	 assessed	 using	 correlation	 analysis	 and	 calculating	 the	
Spearman’s	 rank	correlation	coefficient	 (r).	The	 results	 are	 presented	 as	 mean	 value	 ±	standard	
deviation	(M±S).	The	difference	was	considered	significant	at	p˂0.05		
	
Results		
General	 characteristics	 and	 lipid	 profile	 in	 CHF	 secondary	 to	 overweight	 and	 obesity	
according	to	gender	are	presented	in	Table	1.	It	should	be	noted	that	women	were	older	(4.4	years,	
p<0.05).	CHF	FC	did	not	have	any	gender-based	differences,	and	the	BMI	 in	men	was	significantly	
lower	than	that	 in	women	 (5.9%).	 In	women	the	 levels	of	TC,	HDL-C,	VLDL-C	and	TG	were	higher	
than	in	men	–	by	8.3%,	11.6%,	8.9%	and	9.3%,	respectively	(p<0.05).	The	level	of	LDL-C	in	women	was	
unreliable	higher.	The	 indicator	of	 the	AC,	 the	LDL-C/HDL-C	and	TG/HDL-C	 ratios	 insignificantly	
dominated	in	men.	
	
Table	1	
General	characteristics	and	lipid	profile	in	patients	with	CHF	secondary	to	overweight	and	obesity	
according	to	gender	
Parameter	
Women	
(n=128)	
Men	
(n=84)	
Age,	years	 65.6±10.1	 61.2±13.4*	
CHF,	FC	 2.02±0.81	 2.01±0.74	
BMI,	kg/m2	 32.3±5.78	 30.5±6.18*	
TC,	mmol/l	 5.47±1.49	 5.05±1.36*	
HDL-C,	mmol/l	 1.35±0.34	 1.21±0.30*	
LDL-C,	mmol/l	 3.26±1.29	 3.11±1.13	
VLDL-C,	mmol/l	 0.86±0.60	 0.79±0.73*	
TG,	mmol/l	 1.89±1.32	 1.73±1.60*	
AC	 3.17±1.08	 3.34±1.35	
LDL-C/	HDL-C	ratio	 2.48±0.88	 2.68±1.11	
TG/	HDI-C	ratio	 1.54±1.20	 1.62±2.14	
Note:		
*	-	the	difference	between	indicators	is	statistically	significant	(p<0.05)	
	
When	analyzing	the	prevalence	of	changes	in	laboratory	parameters	in	CHF	there	were	no	
significant	gender-based	differences	 (Table	2).	Elevated	 levels	of	atherogenic	TC,	LDL-C,	VLDL-C,	
TG,	and	 low	 levels	of	anti-atherogenic	HDL-C	predominated	 in	women.	The	 frequency	of	normal	
and	low	levels	of	TC,	HDL-C,	LDL-C,	VLDL-C	and	TG	was	greater	in	men.	Elevated	levels	of	the	AC,	
the	 LDL-C/HDL-C	 ratio	 were	 more	 often	 observed	 in	 men,	 and	 the	 TG/HDL-C	 ratio	 was	 more	
prevalent	among	women.	
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Table	2	
Prevalence	of	changes	in	parameters	of	lipid	metabolism	in	patients	with	CHF	secondary	to	
overweight	and	obesity	according	to	gender	
Parameter	
Women	
(n=128)	
Men	
(n=84)	
TC>5	mmol/l,	n	(%)	
TC	3.2	-	5	mmol/l,	n	(%)	
TC˂3.2	mmol/l,	n	(%)	
81	(63.28)	
40	(31.25)	
7	(5.47)	
43	(51.2)	
(41.67)	
6	(7.0%)	
HDL-C˂1.0	in	men,	and	˂1.3	in	women	n	(%)	
HDL-C>1.0	in	men,	and	>1.3	in	women	n	(%)	
53	(41.4)	
75	(58.6)	
19	(22.6)	
65	(77.4)	
LDL-C>3	mmol/l,	n	(%)	
LDL-C	2-3	mmol/l,	n	(%)	
LDL-C˂2	mmol/l,	n	(%)	
71	(55.5)	
38	(29.7)	
19	(14.8)	
38	(45.2)	
31	(36.9)	
15	(17.9)	
VLDL-C>1.0	mmol/l,	n	(%)	
VLDL-C˂1.0	mmol/l,	n	(%)	
28	(21.9)	
100	(78.1)	
16	(19.0)	
68	(81.0)	
TG>1.7	mmol/l,	n	(%)	
TG	0.5-1.7	mmol/l,	n	(%)	
TG˂0.50	mmol/l,	n	(%)	
50	(39.1)	
78	(60.9)	
-	
27	(32.1)	
55	(65.5)	
2	(2.4)	
AC>3.0,	n	(%)	
AC˂3.0,	n	(%)	
61	(47.7)	
67	(52.3)	
47	(56.0)	
37	(44)	
LDL-C/HDL-C	ratio	>2.26,	n	(%)	
LDL-C/HDL-C	ratio˂2.26,	n	(%)	
72	(56.3)	
56	(43.7)	
49	(58.3)	
35	(41.7)	
TG/HDL-C	ratio>1.48,	n	(%)	
TG/HDL-C	ratio˂1.48,	n	(%)	
45	(35.2)	
83	(64.8)	
28	(33.3)	
56	(66.7)	
	 	
The	 results	of	studying	age-related	peculiarities	of	 lipid	metabolism	 in	patients	with	CHF	
secondary	 to	overweight	and	obesity	are	presented	 in	Table	3.	Among	young	patients	men	 (38%)	
dominated;	women	(54.4%)	were	more	often	observed	among	elderly	patients.	Equal	distribution	of	
patients	 according	 to	 gender	 was	 observed	 among	 middle-aged	 patients;	 among	 senile	 patients	
women	dominated.	The	number	of	women	among	elderly	patients	was	greater	compared	to	young	
and	 middle-aged	 patients	 -	 41.7%	 and	 22.7%,	 respectively,	 p<0.05.	 The	 opposite	 changes	 were	
observed	among	men.	The	progression	of	CHF	with	age	manifested	as	a	 reliable	 increase	 in	 the	
average	value	of	FC	of	the	disease	was	observed.	In	the	first	two	age	groups	there	was	a	tendency	
to	an	 increase	 in	FC	of	CHF.	The	 indicators	of	elderly	and	senile	groups	being	different	between	
themselves	(29.8%,	p<0.05)	were	significantly	higher	–	by	33.1%	and	23.5%	and	by	72.7%	and	60.2%,	
respectively.	The	BMI	in	the	first	three	groups	had	a	tendency	to	decrease;	in	senile	patients	it	was	
the	lowest	and	yielded	the	values	of	young	and	middle-aged	patients	–	14.7%	and	9.8%,	respectively,	
p<0.05.	There	was	no	significant	difference	 in	the	 levels	of	TC	and	LDL-C;	maximum	values	were	
observed	 in	 young	 patients;	 minimum	 values	 were	 detected	 in	 senile	 patients.	 There	 was	 a	
tendency	to	increase	in	the	concentration	of	HDL-C	with	increasing	age.	Maximum	values	of	VLDL-
C	were	observed	in	young	and	middle-aged	patients	significantly	yielding	those	in	elderly	(by	49.3%	
and	33.3%,	respectively)	and	senile	 (by	69.7%	and	51.5%,	respectively)	patients.	The	 level	of	TG	 in	
young	 patients	 exceeded	 that	 in	 elderly	 and	 senile	 patients	 -	 by	 48.5%	 and	 67.8%,	 respectively,	
(p<0.05).	The	 concentration	of	TG	 in	middle-aged	patients	 significantly	 exceeded	 that	 in	 elderly	
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patients	–	by	33.9%	and	51.4%,	respectively.	With	increasing	age	there	was	a	decrease	in	the	AC;		in	
young	patients	 this	parameter	exceeded	 that	 in	elderly	and	senile	patients	–	by	27.2%	and	31.5%,	
respectively	 (p<0.05).	The	LDL-C/HDL-C	 ratio	 tended	 to	decrease	with	aging	while	 the	TG/HDL-C	
ratio	decreased	significantly.	Maximum	value	of	TG/HDL-C	ratio	was	observed	 in	young	patients;	
it	was	significantly	higher	than	that	in	elderly	and	senile	patients	–	by	63%	and	78.9%,	respectively.	
The	TG/HDL-C	ratio	in	middle-aged	patients	exceeded	that	in	elderly	and	senile	patients	-	by	47.4%	
and	 61.8%,	 respectively,	 p<0.05.	 There	 were	 significant	 correlations	 of	 age	 with	 the	 following	
parameters	 of	 lipid	 metabolism:	 VLDL-C	 (r=-0.17),	 TG	 (r=-0.17),	 AC	 (r=-0.16),	 TG/HDL-C	 ratio	 (r=-
0.19).		
	
Table	3	
General	characteristics	and	parameters	of	lipid	profile	in	patients	with	CHF	secondary	to	
overweight	and	obesity	depending	on	age	
Parameter	
˂45	years	
(n=13)	
45-59	
years	
(n=62)	
60-74	years	
(n=99)	
75-89	years	
(n=38)	
Women,	n	(%)	 4	(31)	 31	(50)	 72	(72.7)*1	 21	(55.3)	
Men,	n	(%)	 9	(69)	 31	(50)	 27	(27.3)*1	 17	(44.7)	
CHF,	FC	 1.54±0.78	 1.66±0.75	 2.05±0.71*1	 2.66±0.58*12	
BMI,	kg/m2	 34.3±5.43	 32.7±6.66	 31.2±5.70	 29.9±5.24*1	
TC,	mmol/l	 5.68±1.38	 5.29±1.30	 5.34±1.64	 5.09±1.18	
HDL-C,	mmol/l	 1.17±0.32	 1.26±0.35	 1.33±0.33	 1.32±0.32	
LDL-C,	mmol/l	 3.38±1.07	 3.15±1.12	 3.25±1.40	 3.10±0.99	
VLDL-C,	mmol/l	 1.12±0.72	 1.0±0.98	 0.75±0.41*1	 0.66±0.32*1	
TG,	mmol/l	 2.45±1.58	 2.21±1.17	 1.65±0.90*1	 1.46±0.70*1	
AC	 3.97±0.94	 3.41±1.35	 3.12±1.08*	 3.02±1.20*	
LDL-C/HDL-C	ratio	 2.95±0.86	 2.64±1.11	 2.50±0.91	 2.46±0.95	
TG/	HDI-C	ratio	 2.20±1.70	 1.99±2.57	 1.35±0.90*1	 1.23±0.80*1	
Notes:		
the	difference	between	indicators	is	statistically	significant	compared	to:		
*-	in	Group	I;		
1	–	in	Group	II,		
2	-	in	Group	III	(p<0.05).	
	 	
There	were	no	significant	age-related	differences	in	the	prevalence	of	changes	in	TC,	HDL-
C	 and	 LDL-C	 significant	 differences	 in	 age	 are	 not	 established.	 The	 increase	 in	 parameters	 was	
observed	 in	young	patients.	Maximum	prevalence	of	elevated	VLDL-C	 levels	was	also	detected	 in	
young	patients	exceeding	 those	 in	middle-aged,	elderly	and	senile	patients	 -	 	by	20.4%,	29%	and	
33%,	respectively,	p<0.05.	There	were	observed	the	opposite	changes	in	frequency	of	normal	levels	
of	 VLDL-C	 increasing	 with	 age.	 The	 prevalence	 of	 elevated	 TG	 levels	 was	 most	 often	 observed	
among	young	patients	exceeding	that	among	middle-aged,	elderly,	and	senile	patients	–	by	28.9%,	
34.9%,	and	45.5%,	respectively,	p<0.05.	With	age,	the	prevalence	of	normal	level	of	TG	increased;	in	
elderly	and	senile	patients	it	was	significantly	greater	compared	to	young	patients	–	by	34.9%	and	
42.9%,	respectively.	Low	levels	of	TG	were	detected	in	1	middle-aged	patient	and	1	senile	patient.	
The	percentage	of	patients	with	high	AC	in	the	first	three	age	groups	had	a	tendency	to	decrease.	
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The	AC	 in	senile	patients	yielded	 that	 in	young	patients	 (by	32.2%,	p<0.05).	There	were	observed	
the	opposite	changes	in	the	prevalence	of	normal	levels	of	AC	increasing	with	age.	There	were	no	
significant	differences	 in	the	prevalence	of	the	LDL-C/HDL-C	ratio.	The	 increase	 in	the	TG/HDL-C	
ratio	was	more	frequently	observed	 in	young	patients	exceeding	that	 in	middle-aged,	elderly	and	
senile	patients	–	by	32.1%,	37.9%	and	42.9%,	respectively,	p<0.05.	The	prevalence	of	normal	TG/HDL-
C	ratio	changes	increasing	with	age	had	the	opposite	changes.	
	
Table	4	
Prevalence	of	changes	in	parameters	of	lipid	metabolism	in	patients	with	CHF	secondary	to	
overweight	and	obesity	depending	on	age	
Paremeter	
˂45	years	
(n=13)	
45-59	years	
(n=62)	
60-74	years	
(n=99)	
75-89	years	
(n=38)	
TC>5	mmol/l,	n	(%)	
TC	3.2	-	5	mmol/l,	n	(%)	
TC˂3.2	mmol/l,	n	(%)	
9	(69.2)	
4	(30.8)	
-	
37	(59.7)	
21	(33.8)	
4	(6.5)	
56	(56.6)	
38	(37.3)	
6	(6.1)	
22	(57.9)	
13	(34.2)	
3	(7.9)	
HDL-C˂1.0	in	men,	and	˂1.3	in	
women	n	(%)	
HDL-C>1.0	in	men,	and	>1.3	in	
women	n	(%)	
6	(46.2)	
7	(53.8)	
19	(30.6)	
43	(69.4)	
34	(34.3)	
65	(65.7)	
13	(34.2)	
25	(65.8)	
LDL-C>3	mmol/l,	n	(%)	
LDL-C	2-3	mmol/l,	n	(%)	
LDL-C˂2	mmol/l,	n	(%)	
8	(61.5)	
4	(30.8)	
1	(7.7)	
32	(51.6)	
30	(32.3)	
10	(16.1)	
49	(49.5)	
33	(33.3)	
17	(17.2)	
20	(52.6)	
12	(31.6)	
6	(15.8)	
VLDL-C>1.0	mmol/l,	n	(%)	
VLDL-C˂1.0	mmol/l,	n	(%)	
6	(46.2)	
7	(53.8)	
16	(25.8)	
46	(74.2)	
17	(17.2)*	
82	(82.8)*	
5	(13.2)*	
33	(86.8)*	
TG>1.7	mmol/l,	n	(%)	
TG	0.5-1.7	mmol/l,	n	(%)	
TG˂0.50	mmol/l,	n	(%)	
9	(69.2)	
4	(30.8)	
-	
25	(40.3)	
36	(58.1)	
1	(1.6)	
34	(34.3)*	
65	(65.7)*	
-	
9	(23.7)*	
28	(73.7)*	
1	(2.6)	
AC>3.0,	n	(%)	
AC˂3.0,	n	(%)	
10	(76.9)	
3	(23.1)	
33	(53.2)	
29	(46.8)	
48	(48.5)	
51	(51.5)	
17	(44.7)*	
21	(55.3)*	
LDL-C/HDL-C	ratio	>2.26,	n	(%)	
LDL-C/HDL-C	ratio˂2.26,	n	(%)	
9	(69.2)	
4	(30.8)	
33	(53.2)	
29	(46.8)	
56	(56.6)	
43	(43.4)	
23	(60.5)	
15	(39.5)	
TG/HDL-C	ratio>1.48,	n	(%)	
TG/HDL-C	ratio˂1.48,	n	(%)	
9	(69.2)	
4	(30.8)	
23	(37.1)*	
39	(62.9)*	
31	(31.3)*	
68	(68.7)*	
10	(26.3)*	
28	(73.7)*	
Note:		
*	-	the	difference	between	indicators	is	statistically	significant	(p<0.05)	
	
Discussion	
Thus,	 in	 CHF	 secondary	 to	 overweight	 and	 obesity	 more	 significant	 disorders	 of	 lipid	
metabolism	manifested	themselves	as	a	predominance	of	atherogenic	TC,	VLDL-C	and	TG	occurred	
in	women.	At	the	same	time,	a	significantly	higher	level	of	antiatherogenic	HDL-C	was	observed	in	
women,	which	may	be	due	 to	 the	higher	 range	of	normal	values,	 the	prevalence	of	 the	BMI	and	
compensatory	 reaction	 of	 the	 organism	 to	 elevated	 levels	 of	 atherogenic	 components	 of	 lipid	
metabolism.	With	age,	there	was	a	significant	reduction	in	the	concentration	of	atherogenic	VLDL-
C,	TG,	AC	and	the	TG/HDL-C	ratio	which	was	accompanied	by	a	significantly	higher	FC	of	CHF	 in	
elderly	and	senile	patients.	The	prevalence	of	high	levels	of	VLDL-C,	TG,	AC	and	the	TG/HDL-C	ratio	
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significantly	decreasing	with	age	was	 the	highest	among	young	patients.	As	a	consequence,	 the	
opposite	 picture	 regarding	 the	 frequency	 of	 detection	 of	 normal	 levels	 of	 these	 parameters	
significantly	 increasing	 with	 age	 was	 observed.	 The	 obtained	 age-related	 changes	 in	 the	
parameters	of	lipid	metabolism	can	be	explained	by	the	decrease	in	functional	activity	of	the	liver	
with	aging	and	more	severe	course	of	CHF,	which	according	to	current	literature	are	accompanied	
by	lower	levels	of	studied	parameters.	
	
Conclusions	
In	CHF	secondary	to	overweight	and	obesity	gender-based	and	age-related	changes	 in	the	
parameters	of	lipid	metabolism	are	represented	by	the	following:	
1.	Both	atherogenic	and	antiatherogenic	components	of	 lipid	metabolism	predominate	 in	
females.	
2.	Age-related	changes	are	presented	by	higher	levels	of	atherogenic	indices	and	prevalence	
of	dyslipidemia	in	young	patients	reducing	with	aging	in	parallel	with	the	deepening	of	CHF.	
	
Prospects	for	further	research	
We	plan	to	study	the	features	of	lipid	metabolism	in	patients	with	CHF	depending	on	degree	
of	excess	weight	and	the	severity	of	the	disease	as	well	as	the	correlation	of	these	parameters	with	
structural	 and	 functional	 indices	 of	 the	 heart,	 concentration	 of	 adipocytokines,	 carbohydrate	
metabolism	and	coagulation	hemostasis.	
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